Comparison of Efficacy and Safety Between Low-Dose Ziprasidone in Combination With Sertraline and Ziprasidone Monotherapy for Treatment-Resistant Patients With Acute Exacerbation Schizophrenia: A Randomized Controlled Trial

Treatment-resistant schizophrenia (TRS) is a prevalent clinical problem with heterogeneous presentations. However, the clinical trial designs for new treatments are still lacking. This study aimed to assess the efficacy of ziprasidone plus sertraline in TRS patients as compared to ziprasidone monoth...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Hui Shi, Jing Xu, Xiaoe Lang, Hanjing Emily Wu, Mei Hong Xiu, Xiang Yang Zhang
Формат: Artigo
Язык:Inglês
Опубликовано: Frontiers Media S.A. 2022-04-01
Серии:Frontiers in Pharmacology
Предметы:
treatment-resistant
ziprasidone
sertraline
efficacy
schizophrenia
acute exacerbation
Online-ссылка:https://www.frontiersin.org/articles/10.3389/fphar.2022.863588/full
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы